Roche CEO Schwan joins chorus of pharma execs blasting COVID patent waiver

Another COVID-19 heavyweight is shunning a controversial measure that would waive intellectual property rights for pandemic drugs and vaccines. But while some executives have simply shrugged off the idea, Roche CEO Severin Schwan says it could lead to a “catastrophe.”